Gynecologic decisions for women at risk for Lynch syndrome

References

• Hampel H, Frankel WL, Martin E et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N. Engl. J. Med.352, 1851–1860 (2005).
   PubMed Web of Science ®Google Scholar
• Vasen HF, Watson P, Mecklin JP et al. The epidemiology of endometrial cancer in hereditary nonpolyposis colorectal cancer. Anticancer Res.14, 1675–1678 (1994).
   PubMed Web of Science ®Google Scholar
• Mecklin JP, Jarvinen HJ. Tumor spectrum in cancer family syndrome (hereditary nonpolyposis colorectal cancer). Cancer68, 1109–1112 (1991).
   PubMed Web of Science ®Google Scholar
• Lindor NM, Rabe K, Petersen GM et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA293, 1979–1985 (2005).
   PubMed Web of Science ®Google Scholar
• Mueller-Koch Y, Vogelsang H, Kopp R et al. Hereditary non-polyposis colorectal cancer: clinical and molecular evidence for a new entity of hereditary colorectal cancer. Gut54, 1733–1740 (2005).
   Google Scholar
• Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis. Colon Rectum34, 424–425 (1991).
   PubMed Web of Science ®Google Scholar
• Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology116, 1453–1456 (1999).
   PubMed Web of Science ®Google Scholar
• Rodriguez-Bigas MA, Boland CR, Hamilton SR et al. A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda guidelines. J. Natl Cancer Inst.89, 1758–1762 (1997).
   PubMedGoogle Scholar
• Bellacosa A, Genuardi M, Anti M, Viel A, Ponz de Leon M. Hereditary nonpolyposis colorectal cancer: review of clinical, molecular genetics, and counseling aspects. Am. J. Med. Genet.62, 353–364 (1996).
   PubMedGoogle Scholar
• Peltomaki P, Vasen HF. Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology113, 1146–1158 (1997).
   PubMed Web of Science ®Google Scholar
• Aaltonen LA, Salovaara R, Kristo P et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N. Engl. J. Med.338, 1481–1487 (1998).
   PubMed Web of Science ®Google Scholar
• Hampel H, Frankel W, Panescu J et al. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res.66, 7810–7817 (2006).
   PubMed Web of Science ®Google Scholar
• Syngal S, Fox EA, Eng C, Kolodner RD, Garber JE. Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1. J. Med. Genet.37, 641–645 (2000).
   Google Scholar
• Balmana J, Stockwell DH, Steyerberg EW et al. Prediction of MLH1 and MSH2 mutations in Lynch syndrome. JAMA296, 1469–1478 (2006).
   PubMedGoogle Scholar
• Barnetson RA, Tenesa A, Farrington SM et al. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N. Engl. J. Med.354, 2751–2763 (2006).
   PubMed Web of Science ®Google Scholar
• Chen S, Wang W, Lee S et al. Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA296, 1479–1487 (2006).
   PubMed Web of Science ®Google Scholar
• Burke W, Petersen G, Lynch P et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium. JAMA277, 915–919 (1997).
   PubMed Web of Science ®Google Scholar
• Lindor NM, Petersen GM, Hadley DW et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA296, 1507–1517 (2006).
   PubMed Web of Science ®Google Scholar
• Smith RA, von Eschenbach AC, Wender R et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001 – testing for early lung cancer detection. CA Cancer J. Clin.51, 38–75 (2001).
   PubMed Web of Science ®Google Scholar
• Jarvinen HJ, Mecklin JP, Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology108, 1405–1411 (1995).
   PubMed Web of Science ®Google Scholar
• Dove-Edwin I, Boks D, Goff S et al. The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma. Cancer94, 1708–1712 (2002).
   PubMedGoogle Scholar
• Renkonen-Sinisalo L, Butzow R, Leminen A, Lehtovirta P, Mecklin JP, Jarvinen HJ. Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome. Int. J. Cancer120, 821–824 (2007).
   PubMedGoogle Scholar
• Kauff ND, Satagopan JM, Robson ME et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N. Engl. J. Med.346, 1609–1615 (2002).
   PubMed Web of Science ®Google Scholar
• Rebbeck TR, Lynch HT, Neuhausen SL et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N. Engl. J. Med.346, 1616–1622 (2002).
   PubMed Web of Science ®Google Scholar
• Anderson K, Jacobson JS, Heitjan DF et al. Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation. Ann. Intern. Med.144, 397–406 (2006).
   PubMed Web of Science ®Google Scholar
• Schmeler KM, Lynch HT, Chen LM et al. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N. Engl. J. Med.354, 261–269 (2006).
   PubMed Web of Science ®Google Scholar
• Chen LM, Yang KY, Little SE, Cheung MK, Caughey AB. Gynecologic cancer prevention in Lynch syndrome/hereditary nonpolyposis colorectal cancer families. Obstet. Gynecol.110, 18–25 (2007).
   PubMed Web of Science ®Google Scholar
• Pasacreta JV. Psychosocial issues associated with genetic testing for breast and ovarian cancer risk: an integrative review. Cancer Invest.21, 588–623 (2003).
   PubMed Web of Science ®Google Scholar
• Gritz ER, Peterson SK, Vernon SW et al. Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer. J. Clin. Oncol.23, 1902–1910 (2005).
   PubMed Web of Science ®Google Scholar
• Geirdal AO, Reichelt JG, Dahl AA et al. Psychological distress in women at risk of hereditary breast/ovarian or HNPCC cancers in the absence of demonstrated mutations. Fam. Cancer4, 121–126 (2005).
   Google Scholar
• Geirdal AO, Maehle L, Heimdal K, Stormorken A, Moller P, Dahl AA. Quality of life and its relation to cancer-related stress in women of families with hereditary cancer without demonstrated mutation. Qual. Life Res.15, 461–470 (2006).
   Google Scholar
• Hadley DW, Jenkins J, Dimond E et al. Genetic counseling and testing in families with hereditary nonpolyposis colorectal cancer. Arch. Intern. Med.163, 573–582 (2003).
   PubMedGoogle Scholar
• Wood NJ, Munot S, Sheridan E, Duffy SR. Does a “one-stop” gynecology screening clinic for women in hereditary nonpolyposis colorectal cancer families have an impact on their psychological morbidity and perception of health? Int. J. Gynecol. Cancer (2007) (Epub ahead of print).
   Google Scholar
• Madalinska JB, Hollenstein J, Bleiker E et al. Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer. J. Clin. Oncol.23, 6890–6898 (2005).
   PubMed Web of Science ®Google Scholar